Stosser et al. analyzed almost 900 patients with pathogenic variants in nine genes associated with epilepsy and found that 3.5% were actually mosaic for the variant, most commonly in CDKL5, PCDH19, SCN2A, and SCN1A genes (Stosser et al., 2018). This evidence concerns the gene SCN2A and epilepsy.